September 11, 2013RetrovirologyOpen Access

The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication

View Full Paper

Ask AI

Bookmark

Structured PICO

Population

In vitro cell lines (peripheral blood mononuclear cells, Jurkat cells, HEK 293T cells, U251MG astrocytic cells) infected with HIV-1 or transfected with HIV-1 molecular clone pNL4-3

Intervention

Overexpression or knockdown (shRNA) of PACT, ADAR1, TRBP, or Staufen1

Comparator

Mock infection/transfection or empty vector controls

Outcome

PKR and eIF2α phosphorylation, HIV-1 protein expression, and virion production (measured by RT activity)surrogate

PACT, typically a PKR activator, acts as a PKR inhibitor during HIV-1 replication, contributing to increased viral protein expression.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

PACT may enhance HIV-1 production via PKR inhibition; hypothesis-generating for host-targeted antivirals, needs human validation.

Cite This Study

Clerzius et al. (2013) studied this question.

synapsesocial.com/papers/6a89c82d9be9d02581bd7f7c https://doi.org/10.1186/1742-4690-10-96

View Full Paper

Ask AI

Bookmark

The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication

Structured PICO

Discussion

Implication

Cite This Study

The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider